1. World Health Organization, “World Health Organization,” 2014.
2. U.S. Department of Health and Human Services Centers for Disease Control and Prevention. “Antibiotic resistance threats in the United States” 2013.
3. P. W. Stone, “Economic burden of healthcare-associated infections: An American perspective,” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 9, no. 5, pp. 417–422, 2009.
4. R. Smith and J. Coast, “The true cost of antimicrobial resistance,” BMJ, vol. 346, no. 7899, Article ID f1493, 2013.
5. D. Botten, G. Fugallo, F. Fraternali, and C. Molteni, “Structural Properties of Green Tea Catechins,” The Journal of Physical Chemistry B, vol. 119, no. 40, pp. 12860–12867, 2015.
6. D. A. Gupta, D. J. Bhaskar, and R. K. Gupta, “Green tea: a review on its natural anti-oxidant therapy and cariostatic benefits,” Biological Sciences and Pharmaceutical Research, vol. 2, pp. 8–12, 2014.
7. Jigisha, R. Nishant, K. Navin et al., “Green tea: a magical herb with miraculous outcomes,” International Research Journal of Pharmacy, vol. 3, no. 5, pp. 139–148, 2012.
8. K. Hayat, H. Iqbal, U. Malik, U. Bilal, and S. Mushtaq, “Tea and its consumption: benefits and risks,” Critical Reviews in Food Science and Nutrition, vol. 55, no. 7, pp. 939–954, 2015.
9. K. D. Crew, K. A. Ho, P. Brown et al., “Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer,” Journal of Human Nutrition and Dietetics, vol. 28, no. 3, pp. 272–282, 2015.
10. M.-J. Li, Y.-C. Yin, J. Wang, and Y.-F. Jiang, “Green tea compounds in breast cancer prevention and treatment,” World Journal of Clinical Oncology, vol. 5, no. 3, pp. 520–528, 2014.
11. Clouatre DL, Kandaswami C, Connolly KM. Grape seed extract. In: Coates PM, Betz JM, Blackman MR, et al., eds. Encyclopedia of Dietary Supplements. 2nd ed. New York, NY: Informa Healthcare; 2010:391-401.
12. Feringa HH, Laskey DA, Dickson JE, et al. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. Journal of the American Dietetic Association. 2011;111(8):1173-1181.
13. Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Alternative Medicine Review. 2000;5(2):144-151.
14. Grape. Natural Medicines Web site. Accessed at naturalmedicines.therapeuticresearch.com/ on April 10, 2015.
15. Kar P, Laight D, Rooprait HK, et al. Effects of grape seed extract in type 2 diabetic subjects at high cardiovascular risk: a double-blind randomized placebo-controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabetic Medicine. 2009;26(5):526-531.

1. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Psychol 1974; 47:211 – 8.
2. Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969; 9:419 – 30.
3. Cheng WS, Murphy TL, Smith MT, Cooksley WG, Halliday JW, Powell LW. Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantative liver function. Clin Pharmacol Ther 1990; 47:516 – 23.
4. Espinola EB, Dias RF, Mattei R, Carlini EA. Pharmacological activity of Guaranan (Paullinia cupana Mart) in laboratory animals. J Ethnopharmacol 1997; 55:223 – 9.
5. “Dorlands Medical Dictionary”. Archived from the original on January 30, 2008.
6. Lanni C, Lenzken SC, Pascale A, et al. (March 2008). “Cognition enhancers between treating and doping the mind”. Pharmacol. Res. 57 (3): 196 213. doi:10.1016/j.phrs.2008.02.004. PMID 18353672.
7. Gazzaniga, Michael S. (2006). The Ethical Brain: The Science of Our Moral Dilemmas
(P.S.). New York, N.Y: Harper Perennial. p. 184. ISBN 0-06-088473-8.
8. Giurgea C (1972). “[Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology] (“Versunepharmacologie de l’active integrative du cerveau: Tentative du concept nootrope en psychopharmacologie”)”. Actual Pharmacol (Paris) (in French) 25: 115–56. PMID 4541214.
9. “Smart Drugs and Should We Take Them?”. Dolan DNA Learning Center. Retrieved November 4, 2012.
10. “Dietary Supplements: What You Need to Know”. US Food and Drug Administration. Retrieved December 27, 2019.